Skip to main content
Barbara Obrien, MD, Gastroenterology, Foley, AL

BarbaraLObrienMD

Gastroenterology Foley, AL

Advanced Endoscopic Interventional

Physician

Dr. Obrien is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Obrien's full profile

Already have an account?

  • Office

    1625 N Alston St
    Foley, AL 36535
    Phone+1 251-970-1954
    Fax+1 251-970-1960

Education & Training

  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoFellowship, Gastroenterology, 1989 - 1992
  • USA Health
    USA HealthResidency, Internal Medicine, 1985 - 1988
  • University of South Alabama College of Medicine
    University of South Alabama College of MedicineClass of 1985

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1986 - 2025
  • OH State Medical License
    OH State Medical License 2021 - 2025
  • IN State Medical License
    IN State Medical License 2020 - 2021
  • WV State Medical License
    WV State Medical License 2020 - 2021
  • IL State Medical License
    IL State Medical License 1988 - 1996
  • MD State Medical License
    MD State Medical License 1991 - 1995
  • TN State Medical License
    TN State Medical License 1992 - 1992
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Solution Series EHR, e-MDs, 2012-2013

Press Mentions

  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) Soars 99% After Enrolling First Patient in Phase 2 Study for Treatment of MGMT-Unmethylated Glioblastoma Multiforme
    DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) Soars 99% After Enrolling First Patient in Phase 2 Study for Treatment of MGMT-Unmethylated Glioblastoma MultiformeJuly 24th, 2019
  • Surviving Oligodendroglioma with Humor and Gratitude
    Surviving Oligodendroglioma with Humor and GratitudeOctober 3rd, 2017